Weighty choices: selecting optimal G-CSF doses for stem cell mobilization to optimize yield
Nosha Farhadfar(University of Florida Health), John R. Wingard(University of Florida Health), Melhem Solh(Johns Hopkins Hospital), Michael A. Pulsipher(Primary Children's Hospital), Siddhartha Ganguly(University of Kansas Medical Center), Christopher Bredeson, Jennifer A. Sees(National Marrow Donor Program), Galen E. Switzer(University of Pittsburgh), Kimberly A. Kasow(University of North Carolina at Chapel Hill), Hemant S. Murthy(University of Florida), Brent R. Logan(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Saurabh Chhabra(Medical College of Wisconsin), Nirali N. Shah(National Institutes of Health), Bronwen E. Shaw(Royal Marsden NHS Foundation Trust), Thomas R. Spitzer(Harvard University), Raquel M. Schears(Mayo Clinic in Arizona), Peiman Hematti(UW Health University Hospital), Hillard M. Lazarus(University Hospitals of Cleveland), Mona Papari, Sachiko Seo(National Cancer Center Hospital East), Donna Przepiorka(The University of Texas MD Anderson Cancer Center), Hisham Abdel‐Azim(University of Southern California), Debra Kelly Lynch(University of Florida Health), Richard F. Olsson(AstraZeneca (Netherlands)), Paolo Anderlini(The University of Texas MD Anderson Cancer Center), Pintip Chitphakdithai(National Marrow Donor Program), Bipin N. Savani(Vanderbilt University Medical Center), Michele W. Sugrue(University of Florida), Miguel Ángel Díaz(Hospital Infantil Universitario Niño Jesús), Rammurti T. Kamble(Baylor College of Medicine), Jean A. Yared(University of Maryland, Baltimore), Jack W. Hsu(University of Florida Health), Dennis L. Confer(National Marrow Donor Program)
Cited by 23
Related Papers
Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
|Clinical Infectious Diseases|2008|4.9k
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
|New England Journal of Medicine|2002|3.3k
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2016|2.8k
Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium
|Clinical Infectious Diseases|2019|2.8k
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
|Clinical Infectious Diseases|2008|2.7k